Latest Administration News

Pacific Edge’s Cxbladder Plus and Triage 1 diagnostic tests are set for significant Medicare reimbursement increases, potentially reshaping the company’s US market prospects.

Austral Resources Australia Ltd reports key operational milestones including completion of Anthill West Pit mining and a strategic MOU with New Frontier Minerals, while progressing its recapitalisation and equity raise plans.

Terra Uranium Limited has expanded its exploration portfolio by acquiring LCT Metals, adding tin and precious metals projects in New South Wales, while advancing uranium exploration in Canada’s Athabasca Basin through strategic partnerships and drill-ready targets.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

eMetals Limited has completed initial field activities at its Busia Gold Project in Uganda, with soil and rock chip sampling underway and results pending. The company also reports ongoing exploration potential at its Mubende Gold Project and maintains a robust cash balance of nearly $3 million.

Hiremii Limited has completed its 2024-25 AI recruitment platform roadmap nine weeks early, with its proprietary AI outperforming industry shortlisting benchmarks. Despite a slight revenue decline due to market slowdowns, the company is poised for growth through technology commercialization and strategic M&A.

Pact Group Holdings has announced its intention to voluntarily delist from the ASX, citing a concentrated shareholder base, low liquidity, and high regulatory costs. Shareholder approval will be sought at an extraordinary general meeting in June 2025.

Fitzroy River Corporation reported steady royalty income for the year ending March 2025, alongside key strategic agreements and a planned capital return, navigating a volatile global energy landscape.

Apollo Minerals reports completion of Phase 2 drilling at its Salanie Gold Project with promising high-grade results, alongside strategic funding and ongoing exploration in Gabon, Serbia, and France.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.

Triangle Energy reported a $9.85 million cash balance for the March quarter, plugged the Becos-1 well after disappointing results, and agreed to defer the Cliff Head asset sale to Pilot Energy until 2026.

Lumos Diagnostics reported a 21% quarter-on-quarter revenue increase in Q3 FY25, driven by strong product sales and expanded development agreements. The company also secured Medicare coverage in key US regions and advanced its pivotal FebriDx CLIA waiver study with FDA submission expected by year-end.